Wael El-Banna Clinic Cairo Egypt Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2019
NCT03945812
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Wael Elbanna Clinic | Wael El-Banna Clinic Cairo Egypt

Active Ingredients

Drugs in Phase 4 Trials (2)

Filgrastim (neupogen) (1 trial)

platelet-rich plasma (1 trial)

Drugs in Other Trials (2)

carbetocin (Pabal) (1 trial)

terlipressin (Terlivaz) (4 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infertility (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 4